Data Portal Core
数据门户核心
基本信息
- 批准号:10678960
- 负责人:
- 金额:$ 33.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-13 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Adipose tissueAffectApplied ResearchBiological MarkersCaringClinical SciencesClinical TrialsCloud ComputingCommunicationCommunitiesComplexConsumptionDataData CollectionData ScienceData SetData SourcesData Storage and RetrievalDemocracyDevelopmentDevicesDimensionsDisparateDoctor of PhilosophyEFRACEchocardiographyEcosystemElectrocardiogramElectronic Health RecordEnsureFAIR principlesFailureFast Healthcare Interoperability ResourcesFundingGoalsHealthHeartHeart failureHeterogeneityHomeImageIndividualInformaticsInfrastructureInsurance CarriersInternetInvestigationKidneyLeadLeadershipLogical Observation Identifiers Names and CodesLungMRI ScansMedicineMobile Health ApplicationMultiomic DataMuscleNational Heart, Lung, and Blood InstituteOnline SystemsParticipantPatientsPhenotypePrivatizationQualifyingRegistriesResearchResearch PersonnelResearch PriorityResourcesStrategic visionSyndromeTest ResultTestingTherapeuticTrans-Omics for Precision MedicineTranslational ResearchTranslationsUnited States Agency for Healthcare Research and QualityUnited States Centers for Medicare and Medicaid ServicesUnited States National Institutes of HealthUniversitiesUpdateVisualizationadvanced analyticsanalytical toolaugmented intelligencebiobankcatalystclinical investigationcohortdata de-identificationdata integrationdata portaldata resourcedata visualizationdiverse dataeffective therapyfrailtyfrontierhealth dataimprovedinteroperabilitymHealthmedical schoolsmembermobile applicationmultiple chronic conditionsmultiple omicsnovelnovel strategiesonline repositorypatient engagementpreservationprogramsremote consentsensorskeletal tissuestemtoolweb appworking group
项目摘要
PROJECT SUMMARY
Given the complexity of the heart failure with preserved ejection fraction (HFpEF) syndrome, there is a major
unmet need to create a comprehensive, resource that can integrate a wide variety of disparate data sources for
consumption by the greater scientific community. A relatively “siloed” approach to scientific investigation in
HFpEF has not resulted in therapeutic advances thus far; therefore, we must pivot to new approaches, including
wider sharing of de-identified data to researchers worldwide to allow for a greater number of novel investigations
using the data. For these reasons, a major advance in the clinical investigation of HFpEF will be the development
of an effective HeartShare Data Portal that capitalizes on the NHLBI BioData Catalyst resource; aggregates,
organizes and curates HeartShare data; and rapidly makes de-identified data available for analysis by qualified
investigators around the world. The NHLBI BioData Catalyst resource is ideally suited for the tasks of the
HeartShare program because it promotes findability, accessibility, interoperability, and reusability (FAIR-ness),
data democratization, robust search/analysis tools, cloud-based computing, and integration with the Trans-
Omics for Precision Medicine (TOPMed) program. It will also support NHLBI’s Strategic Vision objective of
leveraging emerging opportunities in data science in order to open new frontiers in HFpEF investigation. We
propose the following specific aims to accomplish the goals of the HeartShare Data Portal core: (1) To create a
comprehensive web-based HeartShare data portal that uses the existing infrastructure of the NHLBI BioData
Catalyst and is accessible to the research community, provides data storage/access and analytic tools, and
supports online phenotype/omics visualization. (2) To integrate data across an ecosystem of diverse datasets
and data resources applicable to HeartShare, including cohort data, clinical trial data, multi-omics data, EHR
data (including integration via the Fast Healthcare Interoperability Resources (FHIR) standard with Center for
Medicare and Medicaid Services and private insurer data), research testing, biomarkers, and an online repository
of de-identified images (e.g., echocardiograms, MRI scans, ECG tracings). (3) To create a comprehensive
patient engagement resource (web- and mobile-based platforms) using the Eureka platform to allow for (1)
remote consenting and completion of forms, (2) a communication portal for participants (with the ability for
patients to view their own individual data and test results, and aggregate HeartShare summary data); and data
collection for home devices, sensors, and mobile health applications.
项目摘要
鉴于心力衰竭与保留的射血分数(HFPEF)综合征的复杂性,有一个主要
未满足创建一个全面的资源,可以整合各种不同的数据源
更大的科学界的消费。一种相对“孤立”的科学研究方法
迄今为止,HFPEF尚未导致热进展。因此,我们必须转向新方法,包括
在全球研究人员中广泛共享De识别的数据,以允许更多的新型调查
使用数据。由于这些原因,HFPEF临床研究的重大进步将是开发
在NHLBI Biodata催化剂资源上大写的有效的心脏数据门户;聚合,
组织和策划心脏病数据;并迅速使被取消识别的数据可用于合格的分析
世界各地的调查人员。 NHLBI Biodata催化剂资源非常适合于该任务
心莎程序程序是因为它促进可发现性,可访问性,互操作性和可重复性(公平性),
数据民主化,强大的搜索/分析工具,基于云的计算以及与Trans的集成
精确医学的OMICS(顶部)计划。它还将支持NHLBI的战略视觉目标
利用数据科学的新兴机会,以便在HFPEF调查中开放新的边界。我们
建议以下具体旨在实现心脏数据门户核心的目标:(1)创建一个
综合基于Web的心脏数据门户使用NHLBI Biodata的现有基础架构
催化剂,研究社区可以使用,提供数据存储/访问和分析工具,以及
支持在线表型/OMICS可视化。 (2)在不同数据集的生态系统中集成数据
以及适用于心脏夏季的数据资源,包括队列数据,临床试验数据,多摩学数据,EHR
数据(包括通过快速医疗保健互操作性资源(FHIR)与中心的集成
Medicare和Medicaid服务以及私人保险公司数据),研究测试,生物标志物和在线存储库
取消识别图像(例如,超声心动图,MRI扫描,ECG示踪)。 (3)创建一个全面的
使用Eureka平台的患者参与资源(基于Web和移动的平台)允许(1)
表格的远程同意和填写,(2)参与者的通信门户(具有
患者查看自己的个人数据和测试结果,并汇总心脏概述数据);和数据
收集家庭设备,传感器和移动健康应用程序。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sanjiv J Shah其他文献
210 - Once-weekly semaglutide in heart failure with preserved ejection fraction and obesity: main results from the STEP-HFpEF trial
- DOI:
10.1016/j.orcp.2024.09.084 - 发表时间:
2024-09-01 - 期刊:
- 影响因子:
- 作者:
Andrew Sindone;Mikhail Kosiborod;Steen Z Abildstrøm;Barry A Borlaug;Javed Butler;Søren Rasmussen;Melanie J Davies;G. Kees Hovingh;Dalane W Kitzman;Marie L Lindegaard;Daniél Vega Møller;Sanjiv J Shah;Marianne Bach Treppendahl;Subodh Verma;Mark C Petrie - 通讯作者:
Mark C Petrie
211 - Once-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes: main results from the STEP-HFpEF DM trial
- DOI:
10.1016/j.orcp.2024.09.085 - 发表时间:
2024-09-01 - 期刊:
- 影响因子:
- 作者:
Andrew Sindone;Mikhail Kosiborod;Mark C Petrie;Barry A Borlaug;Javed Butler;Melanie J Davies;G. Kees Hovingh;Dalane W Kitzman;Daniél Vega Møller;Marianne Bach Treppendahl;Subodh Verma;Thomas J Jensen;Karoline Liisberg;Marie L Lindegaard;Sanjiv J Shah - 通讯作者:
Sanjiv J Shah
Sanjiv J Shah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sanjiv J Shah', 18)}}的其他基金
相似国自然基金
考虑扭翘二次剪力流影响的非对称截面薄壁箱梁畸变理论及其应用研究
- 批准号:52368020
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
考虑有向影响的概率不确定语言T球形模糊多属性群决策理论、方法与应用研究
- 批准号:72361026
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
阶层流动性对消费者慈善行为的多维影响和应用研究:基于共同富裕的需求视角
- 批准号:72302130
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
异常应力影响椎间盘微环境导致椎间盘退变的机制及应用研究
- 批准号:82330074
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
基于数据点相互影响的多阶密度聚类算法及其在大气污染时空数据中的应用研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
Development and Application of Muscle Diffusion Tensor MRI
肌肉弥散张量MRI的发展及应用
- 批准号:
10400490 - 财政年份:2019
- 资助金额:
$ 33.77万 - 项目类别:
Development and Application of Muscle Diffusion Tensor MRI
肌肉弥散张量MRI的发展及应用
- 批准号:
9926824 - 财政年份:2019
- 资助金额:
$ 33.77万 - 项目类别:
Roles of Lipid Metabolism in Regulation of Longevity
脂质代谢在长寿调节中的作用
- 批准号:
7770322 - 财政年份:2009
- 资助金额:
$ 33.77万 - 项目类别: